Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement

Diabetic retinopathy (DR) is an emerging preventable cause of blindness in India. All India Ophthalmology Society (AIOS) and Vitreo-Retinal Society of India (VRSI) have initiated several measures to improve of DR screening in India. This article is a consensus statement of the AIOS DR task force and...

Full description

Bibliographic Details
Main Authors: Rajiv Raman, Kim Ramasamy, Ramachandran Rajalakshmi, Sobha Sivaprasad, S Natarajan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=3;spage=678;epage=688;aulast=Raman
id doaj-3886d9f75b2441cba29e27d68e49b2de
record_format Article
spelling doaj-3886d9f75b2441cba29e27d68e49b2de2021-03-31T06:16:24ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892021-01-0169367868810.4103/ijo.IJO_667_20Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus StatementRajiv RamanKim RamasamyRamachandran RajalakshmiSobha SivaprasadS NatarajanDiabetic retinopathy (DR) is an emerging preventable cause of blindness in India. All India Ophthalmology Society (AIOS) and Vitreo-Retinal Society of India (VRSI) have initiated several measures to improve of DR screening in India. This article is a consensus statement of the AIOS DR task force and VRSI on practical guidelines of DR screening in India. Although there are regional variations in the prevalence of diabetes in India at present, all the States in India should screen their population for diabetes and its complications. The purpose of DR screening is to identify people with sight-threatening DR (STDR) so that they are treated promptly to prevent blindness. This statement provides strategies for the identification of people with diabetes for DR screening, recommends screening intervals in people with diabetes with and without DR, and describes screening models that are feasible in India. The logistics of DR screening emphasizes the need for dynamic referral pathways with feedback mechanisms. It provides the clinical standards required for DR screening and treatment of STDR and addresses the governance and quality assurance (QA) standards for DR screening in Indian settings. Other aspects incorporate education and training, recommendations on Information technology (IT) infrastructure, potential use of artificial intelligence for grading, data capture, and requirements for maintenance of a DR registry. Finally, the recommendations include public awareness and the need to work with diabetologists to control the risk factors so as to have a long-term impact on prevention of diabetes blindness in India.http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=3;spage=678;epage=688;aulast=Ramanconsensusdiabetic retinopathy screeningguidelinesindia
collection DOAJ
language English
format Article
sources DOAJ
author Rajiv Raman
Kim Ramasamy
Ramachandran Rajalakshmi
Sobha Sivaprasad
S Natarajan
spellingShingle Rajiv Raman
Kim Ramasamy
Ramachandran Rajalakshmi
Sobha Sivaprasad
S Natarajan
Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement
Indian Journal of Ophthalmology
consensus
diabetic retinopathy screening
guidelines
india
author_facet Rajiv Raman
Kim Ramasamy
Ramachandran Rajalakshmi
Sobha Sivaprasad
S Natarajan
author_sort Rajiv Raman
title Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement
title_short Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement
title_full Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement
title_fullStr Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement
title_full_unstemmed Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement
title_sort diabetic retinopathy screening guidelines in india: all india ophthalmological society diabetic retinopathy task force and vitreoretinal society of india consensus statement
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Ophthalmology
issn 0301-4738
1998-3689
publishDate 2021-01-01
description Diabetic retinopathy (DR) is an emerging preventable cause of blindness in India. All India Ophthalmology Society (AIOS) and Vitreo-Retinal Society of India (VRSI) have initiated several measures to improve of DR screening in India. This article is a consensus statement of the AIOS DR task force and VRSI on practical guidelines of DR screening in India. Although there are regional variations in the prevalence of diabetes in India at present, all the States in India should screen their population for diabetes and its complications. The purpose of DR screening is to identify people with sight-threatening DR (STDR) so that they are treated promptly to prevent blindness. This statement provides strategies for the identification of people with diabetes for DR screening, recommends screening intervals in people with diabetes with and without DR, and describes screening models that are feasible in India. The logistics of DR screening emphasizes the need for dynamic referral pathways with feedback mechanisms. It provides the clinical standards required for DR screening and treatment of STDR and addresses the governance and quality assurance (QA) standards for DR screening in Indian settings. Other aspects incorporate education and training, recommendations on Information technology (IT) infrastructure, potential use of artificial intelligence for grading, data capture, and requirements for maintenance of a DR registry. Finally, the recommendations include public awareness and the need to work with diabetologists to control the risk factors so as to have a long-term impact on prevention of diabetes blindness in India.
topic consensus
diabetic retinopathy screening
guidelines
india
url http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=3;spage=678;epage=688;aulast=Raman
work_keys_str_mv AT rajivraman diabeticretinopathyscreeningguidelinesinindiaallindiaophthalmologicalsocietydiabeticretinopathytaskforceandvitreoretinalsocietyofindiaconsensusstatement
AT kimramasamy diabeticretinopathyscreeningguidelinesinindiaallindiaophthalmologicalsocietydiabeticretinopathytaskforceandvitreoretinalsocietyofindiaconsensusstatement
AT ramachandranrajalakshmi diabeticretinopathyscreeningguidelinesinindiaallindiaophthalmologicalsocietydiabeticretinopathytaskforceandvitreoretinalsocietyofindiaconsensusstatement
AT sobhasivaprasad diabeticretinopathyscreeningguidelinesinindiaallindiaophthalmologicalsocietydiabeticretinopathytaskforceandvitreoretinalsocietyofindiaconsensusstatement
AT snatarajan diabeticretinopathyscreeningguidelinesinindiaallindiaophthalmologicalsocietydiabeticretinopathytaskforceandvitreoretinalsocietyofindiaconsensusstatement
_version_ 1724178244203184128